Slungaard A, Mahoney J R
Department of Internal Medicine, University of Minnesota Medical School, Minneapolis 55455.
J Exp Med. 1991 Jan 1;173(1):117-26. doi: 10.1084/jem.173.1.117.
Eosinophilic endocarditis is a potentially lethal complication of chronic peripheral blood hypereosinophilia. We hypothesized that eosinophil peroxidase (EPO), an abundant eosinophil (EO) cationic granule protein, promotes eosinophilic endocarditis by binding to negatively charged endocardium, and there generating cytotoxic oxidants. Using an immunocytochemical technique, we demonstrated endocardial deposition of EPO in the heart of a patient with hypereosinophilic heart disease. Because EPO preferentially oxidizes Br- to hypobromous acid (HOBr) rather than Cl- to hypochlorous acid (HOCl) at physiologic halide concentrations, we characterized the Br(-)-dependent toxicity of both activated EOs and purified human EPO towards several types of endothelial cells and isolated working rat hearts. In RPMI supplemented with 100 microM Br-, phorbol myristate acetate-activated EOs, but not polymorphonuclear leukocytes, caused 1.8-3.6 times as much 51Cr release from four types of endothelial cell monolayers as in RPMI alone. H2O2 and purified human EPO, especially when bound to cell surfaces, mediated extraordinarily potent, completely Br(-)-dependent cytolysis of endothelial cells that was reversed by peroxidase inhibitors, HOBr scavengers, and competitive substrates. We further modeled eosinophilic endocarditis by instilling EPO into the left ventricles of isolated rat hearts, flushing unbound EPO, then perfusing them with a buffer containing 100 microM Br- and 1 microM H2O2. Acute congestive heart failure (evidenced by a precipitous decrement in rate pressure product, stroke volume work, aortic output, and MVO2 to 0-33% of control values) ensued over 20 min, which deletion of EPO, Br-, or H2O2 completely abrogated. These findings raise the possibility that EPO bound to endocardial cells might utilize H2O2 generated either by overlying phagocytes or endogenous cardiac metabolism along with the virtually inexhaustible supply of Br- from flowing blood to fuel HOBr-mediated cell damage. By this mechanism, EPO may play an important role in the pathogenesis of eosinophilic endocarditis.
嗜酸性粒细胞性心内膜炎是慢性外周血嗜酸性粒细胞增多症的一种潜在致命并发症。我们推测,嗜酸性粒细胞过氧化物酶(EPO)是一种丰富的嗜酸性粒细胞(EO)阳离子颗粒蛋白,它通过与带负电荷的心内膜结合并在那里产生细胞毒性氧化剂来促进嗜酸性粒细胞性心内膜炎。使用免疫细胞化学技术,我们在一名嗜酸性粒细胞增多性心脏病患者的心脏中证实了EPO的心内膜沉积。由于在生理卤化物浓度下,EPO优先将Br-氧化为次溴酸(HOBr),而不是将Cl-氧化为次氯酸(HOCl),我们表征了活化的EO和纯化的人EPO对几种类型的内皮细胞和离体工作大鼠心脏的Br(-)依赖性毒性。在补充有100μM Br-的RPMI中,佛波酯激活的EO而非多形核白细胞导致四种类型的内皮细胞单层的51Cr释放量比单独的RPMI中高1.8至3.6倍。H2O2和纯化的人EPO,特别是当它们与细胞表面结合时,介导了异常强效的、完全依赖Br(-)的内皮细胞溶解,而过氧化物酶抑制剂、HOBr清除剂和竞争性底物可逆转这种溶解。我们通过将EPO注入离体大鼠心脏的左心室,冲洗未结合的EPO,然后用含有100μM Br-和1μM H2O2的缓冲液灌注它们,进一步模拟嗜酸性粒细胞性心内膜炎。20分钟内出现急性充血性心力衰竭(表现为心率压力乘积、每搏量功、主动脉输出和MVO2急剧下降至对照值的0 - 33%),而去除EPO、Br-或H2O2可完全消除这种情况。这些发现增加了这样一种可能性,即与心内膜细胞结合的EPO可能利用覆盖的吞噬细胞产生的H2O2或内源性心脏代谢产物,以及来自流动血液中几乎取之不尽的Br-供应,来引发HOBr介导的细胞损伤。通过这种机制,EPO可能在嗜酸性粒细胞性心内膜炎的发病机制中起重要作用。